Quick Answer
SUPERNUS PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 57.46 million shares for the year ending 2025.
- SUPERNUS PHARMACEUTICALS, INC. showed an increase of +3.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from SUPERNUS PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: 1.68 million shares | Q2 2012: 24.46 million shares | Q3 2012: 24.47 million shares | Q1 2013: 30.89 million shares | Q3 2013: 30.95 million shares | Q1 2014: 42.05 million shares | Q2 2014: 42.14 million shares | Q3 2014: 42.93 million shares | Q1 2015: 47.51 million shares | Q2 2015: 48.44 million shares | Q3 2015: 48.69 million shares | Q1 2016: 49.42 million shares | Q2 2016: 49.51 million shares | Q3 2016: 49.54 million shares | Q1 2017: 50.23 million shares | Q2 2017: 50.73 million shares | Q3 2017: 51.26 million shares | Q1 2018: 51.63 million shares | Q2 2018: 52.18 million shares | Q3 2018: 52.26 million shares | Q1 2019: 52.37 million shares | Q2 2019: 52.45 million shares | Q3 2019: 52.46 million shares | Q1 2020: 52.54 million shares | Q2 2020: 52.62 million shares | Q3 2020: 52.67 million shares | Q1 2021: 52.87 million shares | Q2 2021: 52.87 million shares | Q3 2021: 52.87 million shares | Q1 2022: 53.26 million shares | Q2 2022: 53.26 million shares | Q3 2022: 53.26 million shares | Q1 2023: 54.25 million shares | Q2 2023: 54.25 million shares | Q3 2023: 54.25 million shares | Q1 2024: 54.72 million shares | Q2 2024: 55.05 million shares | Q3 2024: 55.22 million shares | Q1 2025: 55.99 million shares | Q2 2025: 56.12 million shares | Q3 2025: 57.12 million shares.
- Over the full 15 years of available data (2011 to 2025), SUPERNUS PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 3,356.5%.
- Historical annual values: Fiscal year 2025: 57.46 million shares | Fiscal year 2024: 55.74 million shares | Fiscal year 2023: 54.72 million shares | Fiscal year 2022: 54.25 million shares | Fiscal year 2021: 53.26 million shares | Fiscal year 2020: 52.87 million shares | Fiscal year 2019: 52.53 million shares | Fiscal year 2018: 52.32 million shares | Fiscal year 2017: 51.31 million shares | Fiscal year 2016: 49.97 million shares | Fiscal year 2015: 49.00 million shares | Fiscal year 2014: 42.97 million shares | Fiscal year 2013: 39.98 million shares | Fiscal year 2012: 30.62 million shares | Fiscal year 2011: 1.66 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: